Screener
Bio-Rad Laboratories BIO Q4 2025 Annual earnings
Reported February 12, 2026 · After market close
Revenue$693.2MBeat by $4.4M
EPS$2.51Miss by $0.06
Revenue estimate$688.8M
EPS estimate$2.57
Next report
Oct 29, 2026 (in a month)Revenue estimate$650.6M
EPS estimate$2.23
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bio-Rad Laboratories report Q4 2025 earnings?
- Bio-Rad Laboratories (BIO) reported Q4 2025 earnings on February 12, 2026 after market close.
- What were Bio-Rad Laboratories's Q4 2025 revenue and EPS?
- Bio-Rad Laboratories reported revenue of $693.2M and eps of $2.51 for Q4 2025.
- Did Bio-Rad Laboratories beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $688.8M by $4.4M. EPS missed the consensus estimate of $2.57 by $0.06.
- How did Bio-Rad Laboratories's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 3.9% from $667.5M a year earlier and eps declined 13.4% from $2.90.
- Where can I find Bio-Rad Laboratories's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0000012208-26-000007) and the 10-K periodic report (0000012208-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.
